Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Santini

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Blood|November 9, 2018
Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trialsU Platzbecker, P Fenaux, L Adès, et al.
Leukemia|June 14, 2017
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemiaV Santini, B Allione, G Zini, et al.
Leukemia|December 30, 2015
Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cellsO A Guryanova, Y K Lieu, F E Garrett-Bakelman, et al.
Leukemia|March 22, 2017
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring SystemM G Della Porta, C H Jackson, E P Alessandrino, et al.
Blood Cancer Journal|September 19, 2015
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatmentD Russo, M Malagola, C Skert, et al.
ESMO Open|March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert ConsensusC Buske, M Dreyling, A Alvarez-Larrán, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Blood|November 9, 2018
Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trialsU Platzbecker, P Fenaux, L Adès, et al.
Leukemia|June 14, 2017
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemiaV Santini, B Allione, G Zini, et al.
Leukemia|December 30, 2015
Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cellsO A Guryanova, Y K Lieu, F E Garrett-Bakelman, et al.
Leukemia|March 22, 2017
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring SystemM G Della Porta, C H Jackson, E P Alessandrino, et al.
Blood Cancer Journal|September 19, 2015
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatmentD Russo, M Malagola, C Skert, et al.
ESMO Open|March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert ConsensusC Buske, M Dreyling, A Alvarez-Larrán, et al.
Pageof 8